{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T19:04:01Z","timestamp":1787771041106,"version":"build-2784847793"},"reference-count":62,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2014,8,26]],"date-time":"2014-08-26T00:00:00Z","timestamp":1409011200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Gastroenterol"],"published-print":{"date-parts":[[2015,4]]},"DOI":"10.1007\/s00535-014-0986-3","type":"journal-article","created":{"date-parts":[[2014,8,25]],"date-time":"2014-08-25T16:30:24Z","timestamp":1408984224000},"page":"480-490","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":41,"title":["miR-33a levels in hepatic and serum after chronic HBV-induced fibrosis"],"prefix":"10.1007","volume":"50","author":[{"given":"Chuan-Feng","family":"Huang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheng-Chao","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fang","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ya-Dong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"De-Jia","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,8,26]]},"reference":[{"issue":"4","key":"986_CR1","doi-asserted-by":"crossref","first-page":"1454","DOI":"10.1002\/hep.24515","volume":"54","author":"IN Guha","year":"2011","unstructured":"Guha IN, Myers RP, Patel K, et al. Biomarkers of liver fibrosis: what lies beneath the receiver operating characteristic curve? Hepatology. 2011;54(4):1454\u201362.","journal-title":"Hepatology"},{"issue":"5","key":"986_CR2","doi-asserted-by":"crossref","first-page":"G709","DOI":"10.1152\/ajpgi.00451.2010","volume":"300","author":"JA Fallowfield","year":"2011","unstructured":"Fallowfield JA. Therapeutic targets in liver fibrosis. Am J Physiol Gastrointest Liver Physiol. 2011;300(5):G709\u201315.","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"issue":"8","key":"986_CR3","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1038\/nrgastro.2010.97","volume":"7","author":"SL Friedman","year":"2010","unstructured":"Friedman SL. Evolving challenges in hepatic fibrosis. Nat Rev Gastroenterol Hepatol. 2010;7(8):425\u201336.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"2","key":"986_CR4","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1002\/hep.23384","volume":"51","author":"L Zhang","year":"2010","unstructured":"Zhang L, Wang G, Hou W, et al. Contemporary clinical research of traditional Chinese medicines for chronic hepatitis B in China: an analytical review. Hepatology. 2010;51(2):690\u20138.","journal-title":"Hepatology"},{"issue":"7","key":"986_CR5","doi-asserted-by":"crossref","first-page":"e242","DOI":"10.1111\/j.1365-2893.2011.01443.x","volume":"18","author":"F Ji","year":"2011","unstructured":"Ji F, Yang B, Peng X, et al. Circulating microRNAs in hepatitis B virus-infected patients. J Viral Hepat. 2011;18(7):e242\u201351.","journal-title":"J Viral Hepat"},{"issue":"1","key":"986_CR6","first-page":"98","volume":"122","author":"YH Zhou","year":"2009","unstructured":"Zhou YH, Wu C, Zhuang H. Vaccination against hepatitis B: the Chinese experience. Chin Med J (Engl). 2009;122(1):98\u2013102.","journal-title":"Chin Med J (Engl)"},{"issue":"1","key":"986_CR7","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/1755-1536-5-12","volume":"5","author":"M Iizuka","year":"2012","unstructured":"Iizuka M, Ogawa T, Enomoto M, et al. Induction of microRNA-214-5p in human and rodent liver fibrosis. Fibrogenesis Tissue Repair. 2012;5(1):12.","journal-title":"Fibrogenesis Tissue Repair"},{"issue":"2","key":"986_CR8","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.cell.2009.01.002","volume":"136","author":"DP Bartel","year":"2009","unstructured":"Bartel DP. MicroRNAs: target recognition and regulatory functions. Cell. 2009;136(2):215\u201333.","journal-title":"Cell"},{"issue":"3","key":"986_CR9","first-page":"83","volume":"3","author":"GC Shukla","year":"2011","unstructured":"Shukla GC, Singh J, Barik S. MicroRNAs: processing maturation, target recognition and regulatory functions. Mol Cell Pharmacol. 2011;3(3):83\u201392.","journal-title":"Mol Cell Pharmacol"},{"issue":"4","key":"986_CR10","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1016\/j.cell.2013.01.031","volume":"152","author":"VC Auyeung","year":"2013","unstructured":"Auyeung VC, Ulitsky I, McGeary SE, et al. Beyond secondary structure: primary-sequence determinants license pri-miRNA hairpins for processing. Cell. 2013;152(4):844\u201358.","journal-title":"Cell"},{"issue":"3","key":"986_CR11","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1038\/nrm2347","volume":"9","author":"G Stefani","year":"2008","unstructured":"Stefani G, Slack FJ. Small non-coding RNAs in animal development. Nat Rev Mol Cell Biol. 2008;9(3):219\u201330.","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"4","key":"986_CR12","doi-asserted-by":"crossref","first-page":"745","DOI":"10.2174\/138161213804581846","volume":"19","author":"F Santa De","year":"2013","unstructured":"De Santa F, Iosue I, Del Rio A, et al. microRNA biogenesis pathway as a therapeutic target for human disease and cancer. Curr Pharm Des. 2013;19(4):745\u201364.","journal-title":"Curr Pharm Des"},{"issue":"1","key":"986_CR13","doi-asserted-by":"crossref","first-page":"27","DOI":"10.2165\/11585010-000000000-00000","volume":"25","author":"L Bavan","year":"2011","unstructured":"Bavan L, Midwood K, Nanchahal J. MicroRNA epigenetics: a new avenue for wound healing research. BioDrugs. 2011;25(1):27\u201341.","journal-title":"BioDrugs"},{"issue":"11","key":"986_CR14","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1093\/abbs\/gmr080","volume":"43","author":"L Zhao","year":"2011","unstructured":"Zhao L, Chen X, Cao Y. New role of microRNA: carcinogenesis and clinical application in cancer. Acta Biochim Biophys Sin (Shanghai). 2011;43(11):831\u20139.","journal-title":"Acta Biochim Biophys Sin (Shanghai)"},{"issue":"6","key":"986_CR15","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1093\/carcin\/bgs140","volume":"33","author":"MV Iorio","year":"2012","unstructured":"Iorio MV, Croce CM. microRNA involvement in human cancer. Carcinogenesis. 2012;33(6):1126\u201333.","journal-title":"Carcinogenesis"},{"key":"986_CR16","doi-asserted-by":"crossref","unstructured":"Stather PW, Sylvius N, Wild JB, et al. Differential MicroRNA expression profiles in peripheral arterial disease Circ Cardiovasc Genet 2013.","DOI":"10.1161\/CIRCGENETICS.111.000053"},{"issue":"6","key":"986_CR17","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1007\/s00592-013-0469-7","volume":"50","author":"C Ciccacci","year":"2013","unstructured":"Ciccacci C, Di Fusco D, Cacciotti L, et al. MicroRNA genetic variations: association with type 2 diabetes. Acta Diabetol. 2013;50(6):867\u201372.","journal-title":"Acta Diabetol"},{"issue":"11","key":"986_CR18","doi-asserted-by":"crossref","first-page":"2339","DOI":"10.1128\/MCB.01714-12","volume":"33","author":"L Goedeke","year":"2013","unstructured":"Goedeke L, Vales-Lara FM, Fenstermaker M, et al. A regulatory role for microRNA 33* in controlling lipid metabolism gene expression. Mol Cell Biol. 2013;33(11):2339\u201352.","journal-title":"Mol Cell Biol"},{"issue":"7369","key":"986_CR19","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1038\/nature10486","volume":"478","author":"KJ Rayner","year":"2011","unstructured":"Rayner KJ, Esau CC, Hussain FN, et al. Inhibition of miR-33a\/b in non-human primates raises plasma HDL and lowers VLDL triglycerides. Nature. 2011;478(7369):404\u20137.","journal-title":"Nature"},{"issue":"22","key":"986_CR20","doi-asserted-by":"crossref","first-page":"9232","DOI":"10.1073\/pnas.1102281108","volume":"108","author":"A Davalos","year":"2011","unstructured":"Davalos A, Goedeke L, Smibert P, et al. miR-33a\/b contribute to the regulation of fatty acid metabolism and insulin signaling. Proc Natl Acad Sci USA. 2011;108(22):9232\u20137.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"5985","key":"986_CR21","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.1126\/science.1189123","volume":"328","author":"SH Najafi-Shoushtari","year":"2010","unstructured":"Najafi-Shoushtari SH, Kristo F, Li Y, et al. MicroRNA-33 and the SREBP host genes cooperate to control cholesterol homeostasis. Science. 2010;328(5985):1566\u20139.","journal-title":"Science"},{"issue":"6","key":"986_CR22","doi-asserted-by":"crossref","first-page":"3756","DOI":"10.1016\/j.bbagen.2013.02.022","volume":"1830","author":"PL Kuo","year":"2013","unstructured":"Kuo PL, Liao SH, Hung JY, et al. MicroRNA-33a functions as a bone metastasis suppressor in lung cancer by targeting parathyroid hormone related protein. Biochim Biophys Acta. 2013;1830(6):3756\u201366.","journal-title":"Biochim Biophys Acta"},{"issue":"5","key":"986_CR23","doi-asserted-by":"crossref","first-page":"922","DOI":"10.4161\/cc.11.5.19421","volume":"11","author":"D Cirera-Salinas","year":"2012","unstructured":"Cirera-Salinas D, Pauta M, Allen RM, et al. Mir-33 regulates cell proliferation and cell cycle progression. Cell Cycle. 2012;11(5):922\u201333.","journal-title":"Cell Cycle"},{"issue":"1","key":"986_CR24","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.cellsig.2013.09.018","volume":"26","author":"ZJ Li","year":"2014","unstructured":"Li ZJ, Ou-Yang PH, Han XP. Profibrotic effect of miR-33a with Akt activation in hepatic stellate cells. Cell Signal. 2014;26(1):141\u20138.","journal-title":"Cell Signal"},{"issue":"3","key":"986_CR25","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1007\/s13277-013-0709-z","volume":"34","author":"J Li","year":"2013","unstructured":"Li J, Liu J, Huang B, et al. Hepatitis B virus infection status is an independent risk factor for multiple myeloma patients after autologous hematopoietic stem cell transplantation. Tumour Biol. 2013;34(3):1723\u20138.","journal-title":"Tumour Biol"},{"issue":"4","key":"986_CR26","doi-asserted-by":"crossref","first-page":"395","DOI":"10.2174\/187153006779025766","volume":"6","author":"R Lafyatis","year":"2006","unstructured":"Lafyatis R. Targeting fibrosis in systemic sclerosis. Endocr Metab Immune Disord Drug Targets. 2006;6(4):395\u2013400.","journal-title":"Endocr Metab Immune Disord Drug Targets"},{"issue":"2","key":"986_CR27","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1053\/jhep.2001.26518","volume":"34","author":"K Ikejima","year":"2001","unstructured":"Ikejima K, Honda H, Yoshikawa M, et al. Leptin augments inflammatory and profibrogenic responses in the murine liver induced by hepatotoxic chemicals. Hepatology. 2001;34(2):288\u201397.","journal-title":"Hepatology"},{"issue":"11","key":"986_CR28","doi-asserted-by":"crossref","first-page":"1600","DOI":"10.1136\/gutjnl-2011-300717","volume":"61","author":"T Ogawa","year":"2012","unstructured":"Ogawa T, Enomoto M, Fujii H, et al. MicroRNA-221\/222 upregulation indicates the activation of stellate cells and the progression of liver fibrosis. Gut. 2012;61(11):1600\u20139.","journal-title":"Gut"},{"issue":"1","key":"986_CR29","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1002\/hep.23922","volume":"53","author":"C Roderburg","year":"2011","unstructured":"Roderburg C, Urban GW, Bettermann K, et al. Micro-RNA profiling reveals a role for miR-29 in human and murine liver fibrosis. Hepatology. 2011;53(1):209\u201318.","journal-title":"Hepatology"},{"key":"986_CR30","first-page":"99","volume":"117","author":"R Weiskirchen","year":"2005","unstructured":"Weiskirchen R, Gressner AM. Isolation and culture of hepatic stellate cells. Methods Mol Med. 2005;117:99\u2013113.","journal-title":"Methods Mol Med"},{"issue":"8","key":"986_CR31","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1111\/j.1440-1746.1998.tb00747.x","volume":"13","author":"GA Ramm","year":"1998","unstructured":"Ramm GA. Isolation and culture of rat hepatic stellate cells. J Gastroenterol Hepatol. 1998;13(8):846\u201351.","journal-title":"J Gastroenterol Hepatol"},{"issue":"2","key":"986_CR32","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1007\/s00795-009-0484-5","volume":"43","author":"A Nakamura","year":"2010","unstructured":"Nakamura A, Ueno T, Yagi Y, et al. Human primary cultured hepatic stellate cells can be cryopreserved. Med Mol Morphol. 2010;43(2):107\u201315.","journal-title":"Med Mol Morphol"},{"issue":"1","key":"986_CR33","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/S0016-5085(03)00695-4","volume":"125","author":"R Bataller","year":"2003","unstructured":"Bataller R, Sancho-Bru P, Gines P, et al. Activated human hepatic stellate cells express the renin-angiotensin system and synthesize angiotensin II. Gastroenterology. 2003;125(1):117\u201325.","journal-title":"Gastroenterology"},{"key":"986_CR34","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1007\/978-1-60761-688-7_3","volume":"640","author":"EL Lecluyse","year":"2010","unstructured":"Lecluyse EL, Alexandre E. Isolation and culture of primary hepatocytes from resected human liver tissue. Methods Mol Biol. 2010;640:57\u201382.","journal-title":"Methods Mol Biol"},{"issue":"5985","key":"986_CR35","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1126\/science.1189862","volume":"328","author":"KJ Rayner","year":"2010","unstructured":"Rayner KJ, Suarez Y, Davalos A, et al. MiR-33 contributes to the regulation of cholesterol homeostasis. Science. 2010;328(5985):1570\u20133.","journal-title":"Science"},{"issue":"8","key":"986_CR36","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1084\/jem.20100035","volume":"207","author":"G Liu","year":"2010","unstructured":"Liu G, Friggeri A, Yang Y, et al. miR-21 mediates fibrogenic activation of pulmonary fibroblasts and lung fibrosis. J Exp Med. 2010;207(8):1589\u201397.","journal-title":"J Exp Med"},{"issue":"6","key":"986_CR37","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1016\/0168-8278(95)80226-6","volume":"22","author":"K Ishak","year":"1995","unstructured":"Ishak K, Baptista A, Bianchi L, et al. Histological grading and staging of chronic hepatitis. J Hepatol. 1995;22(6):696\u20139.","journal-title":"J Hepatol"},{"issue":"6","key":"986_CR38","first-page":"1513","volume":"19","author":"VJ Desmet","year":"1994","unstructured":"Desmet VJ, Gerber M, Hoofnagle JH. et al. Classification of chronic hepatitis: diagnosis, grading and staging Hepatology. 1994;19(6):1513\u201320.","journal-title":"Classification of chronic hepatitis: diagnosis, grading and staging Hepatology"},{"issue":"1","key":"986_CR39","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1111\/j.1582-4934.2006.tb00292.x","volume":"10","author":"AM Gressner","year":"2006","unstructured":"Gressner AM, Weiskirchen R. Modern pathogenetic concepts of liver fibrosis suggest stellate cells and TGF-beta as major players and therapeutic targets. J Cell Mol Med. 2006;10(1):76\u201399.","journal-title":"J Cell Mol Med"},{"issue":"9","key":"986_CR40","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1038\/nrgastro.2013.87","volume":"10","author":"G Szabo","year":"2013","unstructured":"Szabo G, Bala S. MicroRNAs in liver disease. Nat Rev Gastroenterol Hepatol. 2013;10(9):542\u201352.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"1","key":"986_CR41","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1002\/hep.23922","volume":"53","author":"C Roderburg","year":"2010","unstructured":"Roderburg C, Urban GW, Bettermann K, et al. Micro-RNA profiling reveals a role for miR-29 in human and murine liver fibrosis. Hepatology. 2010;53(1):209\u201318.","journal-title":"Hepatology"},{"issue":"12","key":"986_CR42","doi-asserted-by":"crossref","first-page":"2268","DOI":"10.1016\/j.cellsig.2012.07.023","volume":"24","author":"Y He","year":"2012","unstructured":"He Y, Huang C, Zhang SP, et al. The potential of microRNAs in liver fibrosis. Cell Signal. 2012;24(12):2268\u201372.","journal-title":"Cell Signal"},{"issue":"4","key":"986_CR43","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1016\/j.jhep.2012.11.022","volume":"58","author":"C Roderburg","year":"2012","unstructured":"Roderburg C, Luedde M, Vargas Cardenas D, et al. miR-133a mediates TGF-beta-dependent derepression of collagen synthesis in hepatic stellate cells during liver fibrosis. J Hepatol. 2012;58(4):736\u201342.","journal-title":"J Hepatol"},{"issue":"7","key":"986_CR44","doi-asserted-by":"crossref","first-page":"1970","DOI":"10.1053\/j.gastro.2011.02.058","volume":"140","author":"J Vergniol","year":"2011","unstructured":"Vergniol J, Foucher J, Terrebonne E, et al. Noninvasive tests for fibrosis and liver stiffness predict 5-year outcomes of patients with chronic hepatitis C. Gastroenterology. 2011;140(7):1970\u20139 1979 e1971\u20131973.","journal-title":"Gastroenterology"},{"issue":"18","key":"986_CR45","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1056\/NEJMoa1209026","volume":"368","author":"HL Janssen","year":"2013","unstructured":"Janssen HL, Reesink HW, Lawitz EJ, et al. Treatment of HCV infection by targeting microRNA. N Engl J Med. 2013;368(18):1685\u201394.","journal-title":"N Engl J Med"},{"issue":"11","key":"986_CR46","doi-asserted-by":"crossref","first-page":"4402","DOI":"10.1073\/pnas.0813371106","volume":"106","author":"K Wang","year":"2009","unstructured":"Wang K, Zhang S, Marzolf B, et al. Circulating microRNAs, potential biomarkers for drug-induced liver injury. Proc Natl Acad Sci USA. 2009;106(11):4402\u20137.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"2","key":"986_CR47","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.jhep.2012.10.015","volume":"58","author":"J Trebicka","year":"2012","unstructured":"Trebicka J, Anadol E, Elfimova N, et al. Hepatic and serum levels of miR-122 after chronic HCV-induced fibrosis. J Hepatol. 2012;58(2):234\u20139.","journal-title":"J Hepatol"},{"issue":"1","key":"986_CR48","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.jhep.2011.04.026","volume":"56","author":"Y Tomimaru","year":"2011","unstructured":"Tomimaru Y, Eguchi H, Nagano H, et al. Circulating microRNA-21 as a novel biomarker for hepatocellular carcinoma. J Hepatol. 2011;56(1):167\u201375.","journal-title":"J Hepatol"},{"issue":"2","key":"986_CR49","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1002\/mc.20712","volume":"50","author":"J Xu","year":"2011","unstructured":"Xu J, Wu C, Che X, et al. Circulating microRNAs, miR-21, miR-122, and miR-223, in patients with hepatocellular carcinoma or chronic hepatitis. Mol Carcinog. 2011;50(2):136\u201342.","journal-title":"Mol Carcinog"},{"issue":"10","key":"986_CR50","doi-asserted-by":"crossref","first-page":"1923","DOI":"10.1016\/j.cellsig.2012.06.003","volume":"24","author":"Y He","year":"2012","unstructured":"He Y, Huang C, Sun X, et al. MicroRNA-146a modulates TGF-beta1-induced hepatic stellate cell proliferation by targeting SMAD4. Cell Signal. 2012;24(10):1923\u201330.","journal-title":"Cell Signal"},{"issue":"10","key":"986_CR51","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1016\/S0399-8320(07)73970-2","volume":"31","author":"SL Friedman","year":"2007","unstructured":"Friedman SL. Liver fibrosis: from mechanisms to treatment. Gastroenterol Clin Biol. 2007;31(10):812\u20134.","journal-title":"Gastroenterol Clin Biol"},{"issue":"4","key":"986_CR52","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1038\/sj.embor.7400943","volume":"8","author":"P Simic","year":"2007","unstructured":"Simic P, Vukicevic S. Bone morphogenetic proteins: from developmental signals to tissue regeneration. Conference on bone morphogenetic proteins. EMBO Rep. 2007;8(4):327\u201331.","journal-title":"EMBO Rep"},{"issue":"4","key":"986_CR53","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1093\/abbs\/gmp018","volume":"41","author":"X Yan","year":"2009","unstructured":"Yan X, Liu Z, Chen Y. Regulation of TGF-beta signaling by Smad7. Acta Biochim Biophys Sin (Shanghai). 2009;41(4):263\u201372.","journal-title":"Acta Biochim Biophys Sin (Shanghai)"},{"issue":"10","key":"986_CR54","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/j.it.2004.07.008","volume":"25","author":"G Monteleone","year":"2004","unstructured":"Monteleone G, Pallone F, MacDonald TT. Smad7 in TGF-beta-mediated negative regulation of gut inflammation. Trends Immunol. 2004;25(10):513\u20137.","journal-title":"Trends Immunol"},{"issue":"2","key":"986_CR55","doi-asserted-by":"crossref","first-page":"141","DOI":"10.2174\/1874467211104020141","volume":"4","author":"MA Briones-Orta","year":"2011","unstructured":"Briones-Orta MA, Tecalco-Cruz AC, Sosa-Garrocho M, et al. Inhibitory Smad7: emerging roles in health and disease. Curr Mol Pharmacol. 2011;4(2):141\u201353.","journal-title":"Curr Mol Pharmacol"},{"issue":"5B","key":"986_CR56","doi-asserted-by":"crossref","first-page":"2130","DOI":"10.1111\/j.1582-4934.2008.00262.x","volume":"12","author":"J Hamzavi","year":"2008","unstructured":"Hamzavi J, Ehnert S, Godoy P, et al. Disruption of the Smad7 gene enhances CCI4-dependent liver damage and fibrogenesis in mice. J Cell Mol Med. 2008;12(5B):2130\u201344.","journal-title":"J Cell Mol Med"},{"issue":"1","key":"986_CR57","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/S0016-5085(03)00666-8","volume":"125","author":"S Dooley","year":"2003","unstructured":"Dooley S, Hamzavi J, Breitkopf K, et al. Smad7 prevents activation of hepatic stellate cells and liver fibrosis in rats. Gastroenterology. 2003;125(1):178\u201391.","journal-title":"Gastroenterology"},{"issue":"2","key":"986_CR58","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1053\/j.gastro.2008.04.038","volume":"135","author":"S Dooley","year":"2008","unstructured":"Dooley S, Hamzavi J, Ciuclan L, et al. Hepatocyte-specific Smad7 expression attenuates TGF-beta-mediated fibrogenesis and protects against liver damage. Gastroenterology. 2008;135(2):642\u201359.","journal-title":"Gastroenterology"},{"issue":"10","key":"986_CR59","doi-asserted-by":"crossref","first-page":"BR394","DOI":"10.12659\/MSM.883479","volume":"18","author":"B Wang","year":"2012","unstructured":"Wang B, Li W, Chen Y, et al. Coexpression of Smad7 and UPA attenuates carbon tetrachloride-induced rat liver fibrosis. Med Sci Monit. 2012;18(10):BR394\u2013401.","journal-title":"Med Sci Monit"},{"issue":"12","key":"986_CR60","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.1038\/labinvest.2010.126","volume":"90","author":"RT Marquez","year":"2010","unstructured":"Marquez RT, Bandyopadhyay S, Wendlandt EB, et al. Correlation between microRNA expression levels and clinical parameters associated with chronic hepatitis C viral infection in humans. Lab Invest. 2010;90(12):1727\u201336.","journal-title":"Lab Invest"},{"key":"986_CR61","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1146\/annurev.cellbio.23.090506.123406","volume":"23","author":"N Bushati","year":"2007","unstructured":"Bushati N, Cohen SM. microRNA functions. Annu Rev Cell Dev Biol. 2007;23:175\u2013205.","journal-title":"Annu Rev Cell Dev Biol"},{"issue":"2","key":"986_CR62","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1038\/nri2252","volume":"8","author":"HF Lodish","year":"2008","unstructured":"Lodish HF, Zhou B, Liu G, et al. Micromanagement of the immune system by microRNAs. Nat Rev Immunol. 2008;8(2):120\u201330.","journal-title":"Nat Rev Immunol"}],"container-title":["Journal of Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00535-014-0986-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00535-014-0986-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00535-014-0986-3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,14]],"date-time":"2019-08-14T04:51:43Z","timestamp":1565758303000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00535-014-0986-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,8,26]]},"references-count":62,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2015,4]]}},"alternative-id":["986"],"URL":"https:\/\/doi.org\/10.1007\/s00535-014-0986-3","relation":{},"ISSN":["0944-1174","1435-5922"],"issn-type":[{"value":"0944-1174","type":"print"},{"value":"1435-5922","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,8,26]]}}}